Category Archives: Drug prices

US Bill on drug prices: Improving Access to Affordable Prescription Drugs Act

Source: www.franken.senate.gov A bill on drug prices has been introduced in US Congress to bring down prescription drug prices. The Improving Access to Affordable Prescription Drugs Act aims to ensure that drug companies put patients before profits and bring relief to families … Continue reading

Posted in Drug prices, Innovation, Transparency, Uncategorized | Leave a comment

Compulsory licensing in Colombia: Leaked documents show aggressive lobbying by Novartis

Novartis has threatened Colombia with international investment arbitration to avoid the issuance of a compulsory license.* The Swiss pharma giant is also turning to Colombian courts in an attempt to kill the price reduction imposed by the authorities over its … Continue reading

Posted in BITS, Pricing, Drugs, Drug prices, ISDS | Leave a comment

The high price of Big Pharma greed

By Leena Menghaney, The Hindu | March 4, 2017 In 2014, an Indian pharmaceutical company was globally the first to receive approval to market a biosimilar, thereby affordable version, of the breast cancer drug Trastuzumab. Almost immediately, Swiss pharmaceutical company Roche, … Continue reading

Posted in Biologics/Biosimilars, Drug prices, Uncategorized | Tagged , , | Leave a comment

MSF calls on Japan and South Korea to drop the harmful RCEP measures

Kobe, Japan/New Delhi 22 February 2017 As 16countries negotiating the Regional Comprehensive Economic Partnership (RCEP)agreement meet next week in Kobe, Japan, for the seventeenth round of negotiations, international medical humanitarian organisation Médecins Sans Frontières (MSF) is appealing tothe Japanese and South … Continue reading

Posted in Data Exclusivity, Drug prices, Generics, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

Breastcancer doesn’t discriminate. Neither should medicine prices

Picture Courtesy: TAC Twitter

Posted in Campaign for Affordable Trastuzumab, Cancer, Drug prices, Uncategorized | Tagged | Leave a comment

US President Donald Trump has called on pharmaceutical bosses to cut “astronomical” drug prices

Source: BBC  During a White House meeting with senior pharmaceutical executives he told the firms to manufacture more of their drugs in the US. However, he also vowed to help the firms by speeding the approval of new medicines and by … Continue reading

Posted in Drug prices, Uncategorized | Leave a comment

Can drug firms increase health-care access, or just their profits?

Anne Aerts, head of Novartis Foundation, addresses a conference in Basel, Switzerland, looking at the role of drug companies in building health systems. (Credit: Kiara Barnes/Novartis) BASEL, Switzerland — The controversial Swiss pharmaceutical company Novartis has started work to expand … Continue reading

Posted in Drug prices, Novartis Case, Uncategorized | 2 Comments